Eagle Asset Management Inc Denali Therapeutics Inc. Transaction History

Eagle Asset Management Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$16.2 - $23.18 $427,469 - $611,650	26,387 Added 9.13%	315,520 $6.77 Million
Q3 2023 Nov 13, 2023	SELL	$20.63 - $30.17 $116,724 - $170,701	-5,658 Reduced 1.92%	289,133 $5.96 Million
Q2 2023 Aug 09, 2023	SELL	$23.37 - $32.96 $190,932 - $269,283	-8,170 Reduced 2.7%	294,791 $8.7 Million
Q1 2023 May 08, 2023	SELL	$21.91 - $32.67 $572,354 - $853,438	-26,123 Reduced 7.94%	302,961 $6.98 Million
Q4 2022 Feb 14, 2023	BUY	$26.28 - $33.92 $1.93 Million - $2.5 Million	73,624 Added 28.82%	329,084 $9.15 Million
Q3 2022 Nov 07, 2022	SELL	$25.97 - $38.53 $214,096 - $317,641	-8,244 Reduced 3.13%	255,460 $7.84 Million
Q2 2022 Aug 10, 2022	BUY	$20.88 - $35.19 $1.25 Million - $2.11 Million	59,854 Added 29.36%	263,704 $7.76 Million
Q1 2022 May 12, 2022	BUY	$29.0 - $47.27 $357,686 - $583,028	12,334 Added 6.44%	203,850 $6.56 Million
Q4 2021 Feb 11, 2022	SELL	$42.59 - $55.02 $2.17 Million - $2.81 Million	-51,029 Reduced 21.04%	191,516 $8.63 Million
Q3 2021 Nov 10, 2021	SELL	$48.48 - $78.23 $2.35 Million - $3.8 Million	-48,558 Reduced 16.68%	242,545 $12.2 Million
Q2 2021 Aug 11, 2021	SELL	$50.3 - $78.44 $1.35 Million - $2.1 Million	-26,759 Reduced 8.42%	291,103 $22.8 Million
Q1 2021 May 14, 2021	BUY	$53.8 - $81.53 $1 Million - $1.52 Million	18,676 Added 6.24%	317,862 $17.8 Million
Q4 2020 Feb 12, 2021	BUY	$36.89 - $93.56 $11 Million - $28 Million	299,186 New	299,186 $25.1 Million

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.13B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.